Portal de Periódicos da CAPES

Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia

2011; American Physical Society; Volume: 301; Issue: 6 Linguagem: Inglês

10.1152/ajplung.00314.2011

1522-1504

Karen K. Mestan, Robin H. Steinhorn,

Birth, Development, and Health

Editorial FocusFetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasiaKaren K. Mestan, and Robin H. SteinhornKaren K. MestanDepartment of Pediatrics, Northwestern University, Chicago, Illinois, and Robin H. SteinhornDepartment of Pediatrics, Northwestern University, Chicago, IllinoisPublished Online:01 Dec 2011https://doi.org/10.1152/ajplung.00314.2011This is the final version - click for previous versionMoreSectionsPDF (39 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat in the early 1990s, Barker and colleagues (4) proposed that early events occurring before birth could produce later onset cardiovascular disease in the adult. This "fetal origins hypothesis" sparked the beginning of a new way of thinking among clinical and basic scientists. Over the years, numerous reports have added to this idea that a key to understanding complex human diseases is to consider the pathology occurring as early as the fetal stages of development (3, 15, 17, 24, 25). The fetal lung appears to be particularly vulnerable to these processes (14). Animal studies have demonstrated marked structural abnormalities and cellular dysfunction secondary to intrauterine processes such as inflammation and hypoxia-ischemia (6, 9, 27). In this issue, Rozance and colleagues (21) utilize a sheep model of hyperthermia-induced placental insufficiency to comprehensively study fetal lung changes of intrauterine growth restriction (IUGR). They provide compelling evidence that the fetal lung is markedly altered by IUGR, with a degree of structural change and cellular dysfunction so significant that IUGR could be considered an independent risk factor for the development of later bronchopulmonary dysplasia (BPD). These and related findings in other animal models, combined with what has been reported in clinical observations, provide compelling evidence for the fetal origins of BPD (5, 16, 18–20).IUGR is a major complication in both full-term and preterm births and a leading cause of perinatal morbidity and mortality. The incidence of IUGR is about 5% of all U.S. births and ranges from 5–12% among preterm births, depending in part on the stringency of definition of growth restriction (12, 26). The known consequences of IUGR include early and late neonatal death, as well as growth abnormalities, cardiopulmonary disease, and neurodevelopmental disabilities in survivors. A large majority of infants born with IUGR survive to neonatal intensive care unit discharge and seemingly do well. However, a growing body of evidence, inspired in part by Barker's hypothesis, now indicates that these infants are at subsequent risk for adult cardiovascular disease, asthma, diabetes, and metabolic syndromes. Fetal programming occurs during a vulnerable period in which adverse environmental factors disrupt cell proliferation and differentiation and alter patterns of epigenetic remodeling (23). The impact of IUGR on preterm infants is even less well understood compared with term infants because these intrauterine processes are invariably disrupted by early delivery, leaving even fewer infants available for longitudinal study.BPD is a complex, multifactorial disease of premature infants and is the most common chronic lung disease of infancy. Both intrauterine and extrauterine factors have been implicated in its pathogenesis. Because the strongest predictor of BPD is an infant's gestational age at birth, the most widely accepted understanding of BPD pathogenesis is that prolonged neonatal or extrauterine exposures (e.g., hyperoxia, mechanical ventilation, and inflammation) to very immature lungs leads to chronic lung injury. However, we now understand that BPD may occur even after little or no exposure to these therapies. Despite considerable advances in management of respiratory failure in preterm infants, a new BPD has emerged that is characterized by disrupted alveolar development and pulmonary vascular remodeling (13), findings that are similar to what is reported in Rozance's sheep model of IUGR (21). First described in the late 1990s, the pathophysiology of the "new BPD" emphasized the impact of intrauterine inflammation on the developing lung, which "primes" the lung for further insult by a host of postnatal exposures (2, 13). Whether intrauterine inflammatory processes are independent of postnatal exposures remains unclear, but it seems more likely that they are interrelated.The role of chronic placental insufficiency as a contributor to BPD pathogenesis is a relatively understudied pathway that is only now gaining recognition (5). It is likely that some degree of placental insufficiency accompanies intrauterine inflammation, and vice versa (7). However, in animal models of endotoxin-induced intrauterine inflammation, we would note that the fetal lung changes are quite distinct from Rozance's IUGR model (21), in that they are characterized by a diffuse infiltration of inflammatory cells and expression of various proinflammatory cytokines. Furthermore, recent clinical data indicate that fetal growth restriction, without evidence of placental or fetal infection or inflammation, is highly predictive of BPD, even after adjustment for many prenatal and neonatal characteristics (5). Rozance's findings (21) in the IUGR model provide an important pathophysiological foundation for this emerging clinical understanding.The findings of decreased pulmonary density and pulmonary artery endothelial cell (PAEC) dysfunction described by Rozance and colleagues (21) perhaps best represent the subgroup of BPD that is complicated by persistently elevated pulmonary arterial pressures and right-heart dysfunction. Pulmonary hypertension (PHTN) in the preterm infant with BPD is an increasingly recognized problem, affecting roughly one-third of infants with moderate-severe BPD (1, 22). PHTN associated with BPD is also associated with greater morbidity and mortality, including more severe BPD, long-term mechanical ventilation support, poor growth and neurodevelopmental outcome, and death attributable to right-heart dysfunction and multi-organ failure (10). There is an increasing awareness that this association occurs frequently in high-risk populations. For instance, in a recent epidemiological study, Slaughter and colleagues (22) reported a 37% incidence of PHTN at 1 mo of life among chronically ventilated infants with BPD. An et al. (1) evaluated 116 infants with very low birth weight with mild to severe BPD and found a 25% prevalence of PHTN by echocardiogram. The prevalence of persistent PHTN among infants with BPD provides supportive evidence that the pulmonary vascular changes and PAEC dysfunction found in the placental insufficiency-IUGR model may be persistent and irreversible.Despite the growing number of infants diagnosed with BPD-associated PHTN in recent years, little continues to be known about specific risk factors. IUGR is perhaps the most biologically plausible intrauterine mechanism. Premature infants who suffer from IUGR are more than twice as likely to develop BPD than their appropriate-for-gestational-age counterparts (5, 16). These clinical observations suggest that impaired somatic growth may alter the fetal lung in a manner that is specific to PHTN and underlying BPD. Recent animal studies have shown that chronic intrauterine stress alters the pulmonary circulation and disrupts critical signaling pathways responsible for promoting normal vascular growth and structure (11). Furthermore, in a hypoxic fetal environment, intrauterine stress also downregulates VEGF and endothelial nitric oxide synthase, disrupts endothelial cell growth, and leads to abnormal pulmonary vascular muscle cell proliferation (8), similar to what Rozance observed (21). Conversely, selective inhibition of VEGF in fetal lambs produced many of the same structural and physiological changes in the pulmonary vasculature (11) and indicates its fundamental importance in the normal sequence of lung and pulmonary vascular development. Further investigation in these complementary animal models is needed to determine whether these structural and functional abnormalities persist toward term gestation in the prematurely born infant. In addition, the postnatal exposures that interactively contribute to ongoing abnormal lung architecture and cellular function require comprehensive study.In summary, fetal animal models provide an important link to understanding the complex pathogenesis of BPD and its complications. Rozance's findings (21) contribute to the growing evidence that the intrauterine milieu programs the fetal lung. Further investigation is needed regarding the extent, timing, and chronicity of these changes, as well as the interaction with postnatal exposures. With the development of newer therapies to treat premature infant lung disease and PHTN, early screening and individualized management for the infant with IUGR may reduce the incidence and severity of BPD.GRANTSThis work was supported in part by grants from the National Heart, Lung, and Blood Institute (HL093302 to K. Mestan and HL-054705 to R. Steinhorn).DISCLOSURESNo conflicts of interest, financial or otherwise, are declared by the authors.REFERENCES1. An HS , Bae EJ , Kim GB , Kwon BS , Beak JS , Kim EK , Kim HS , Choi JH , Noh CI , Yun YS. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 40: 131–136, 2010.Crossref | PubMed | Google Scholar2. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 18: 1–9, 2001.Crossref | PubMed | ISI | Google Scholar3. Barker DJ. Maternal nutrition and cardiovascular disease. Nutr Health 9: 99–106, 1993.Crossref | PubMed | Google Scholar4. Barker DJ , Gluckman PD , Godfrey KM , Harding JE , Owens JA , Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938–941, 1993.Crossref | PubMed | ISI | Google Scholar5. Bose C , Van Marter LJ , Laughon M , O'Shea TM , Allred EN , Karna P , Ehrenkranz RA , Boggess K , Leviton A. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124: e450–e458, 2009.Crossref | PubMed | ISI | Google Scholar6. Braems G. Fetal hypoxemia on a molecular level: adaptive changes in the hypothalamic-pituitary-adrenal (HPA) axis and the lungs. Eur J Obstet Gynecol Reprod Biol 110, Suppl 1: S63–S69, 2003.Crossref | PubMed | ISI | Google Scholar7. Cheah FC , Jobe AH , Moss TJ , Newnham JP , Kallapur SG. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamnionitis model. Pediatr Res 63: 274–279, 2008.Crossref | PubMed | ISI | Google Scholar8. Chen B , Calvert AE , Cui H , Nelin LD. Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase. Am J Physiol Lung Cell Mol Physiol 297: L1151–L1159, 2009.Link | ISI | Google Scholar9. Compernolle V , Brusselmans K , Acker T , Hoet P , Tjwa M , Beck H , Plaisance S , Dor Y , Keshet E , Lupu F , Nemery B , Dewerchin M , Van Veldhoven P , Plate K , Moons L , Collen D , Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702–710, 2002.Crossref | PubMed | ISI | Google Scholar10. Farquhar M , Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev 11: 149–153, 2010.Crossref | PubMed | ISI | Google Scholar11. Grover TR , Parker TA , Zenge JP , Markham NE , Kinsella JP , Abman SH. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284: L508–L517, 2003.Link | ISI | Google Scholar12. Hoyert DL , Mathews TJ , Menacker F , Strobino DM , Guyer B. Annual summary of vital statistics: 2004. Pediatrics 117: 168–183, 2006.Crossref | PubMed | ISI | Google Scholar13. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641–643, 1999.Crossref | PubMed | ISI | Google Scholar14. Joss-Moore LA , Albertine KH , Lane RH. Epigenetics and the developmental origins of lung disease. Mol Genet Metab 104: 61–66, 2011.Crossref | PubMed | ISI | Google Scholar15. Kanaka-Gantenbein C. Fetal origins of adult diabetes. Ann NY Acad Sci 1205: 99–105, 2010.Crossref | PubMed | ISI | Google Scholar16. Lal MK , Manktelow BN , Draper ES , Field DJ. Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study. Pediatrics 111: 483–487, 2003.Crossref | PubMed | ISI | Google Scholar17. Law CM , Barker DJ , Richardson WW , Shiell AW , Grime LP , Armand-Smith NG , Cruddas AM. Thinness at birth in a northern industrial town. J Epidemiol Community Health 47: 255–259, 1993.Crossref | PubMed | ISI | Google Scholar18. Lipsett J , Tamblyn M , Madigan K , Roberts P , Cool JC , Runciman SI , McMillen IC , Robinson J , Owens JA. Restricted fetal growth and lung development: a morphometric analysis of pulmonary structure. Pediatr Pulmonol 41: 1138–1145, 2006.Crossref | PubMed | ISI | Google Scholar19. Maritz GS , Cock ML , Louey S , Joyce BJ , Albuquerque CA , Harding R. Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis. Pediatr Pulmonol 32: 201–210, 2001.Crossref | PubMed | ISI | Google Scholar20. Reiss I , Landmann E , Heckmann M , Misselwitz B , Gortner L. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet 269: 40–44, 2003.Crossref | PubMed | Google Scholar21. Rozance PJ , Seedorf GJ , Brown A , Roe G , O'Meara MC , Gien J , Tang J , Abman SH. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 301: L860–L871, 2011.Link | ISI | Google Scholar22. Slaughter JL , Pakrashi T , Jones DE , South AP , Shah TA. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 31: 635–640, 2011.Crossref | PubMed | ISI | Google Scholar23. Tamashiro KL , Moran TH. Perinatal environment and its influences on metabolic programming of offspring. Physiol Behav 100: 560–566, 2010.Crossref | PubMed | ISI | Google Scholar24. Thompson JA , Regnault TR. In utero origins of adult insulin resistance and vascular dysfunction. Semin Reprod Med 29: 211–224, 2011.Crossref | PubMed | ISI | Google Scholar25. Xita N , Tsatsoulis A. Fetal origins of the metabolic syndrome. Ann NY Acad Sci 1205: 148–155, 2010.Crossref | PubMed | ISI | Google Scholar26. Zeitlin J , El Ayoubi M , Jarreau PH , Draper ES , Blondel B , Kunzel W , Cuttini M , Kaminski M , Gortner L , Van Reempts P , Kollee L , Papiernik E. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 157: 733–739 e731, 2010.Crossref | PubMed | ISI | Google Scholar27. Zhan CY , Yuan TM , Sun Y , Yu HM. Early gestational intrauterine infection induces postnatal lung inflammation and arrests lung development in a rat model. J Matern Fetal Neonatal Med 24: 213–222, 2011.Crossref | PubMed | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: R. H. Steinhorn, Dept. of Pediatrics, Northwestern Univ. Feinberg School of Medicine, Div. of Neonatology, 2300 Children's Plaza, Box 45, Chicago, IL 60614 (e-mail: [email protected]edu). Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByNovel functional role of GH/IGF-I in neonatal lung myofibroblasts and in rat lung growth after intrauterine growth restrictionJawed Nawabi, Christina Vohlen, Katharina Dinger, Chansutha Thangaratnarajah, Christian Klaudt, Eva Lopez Garcia, Dharmesh V. Hirani, Pinar Haznedar Karakaya, Iris Macheleidt, Margarete Odenthal, Kai D. Nüsken, Jörg Dötsch, and Miguel A. Alejandre Alcazar12 October 2018 | American Journal of Physiology-Lung Cellular and Molecular Physiology, Vol. 315, No. 5Intra-Amniotic Soluble Endoglin Impairs Lung Development in Neonatal RatsAmerican Journal of Respiratory Cell and Molecular Biology, Vol. 57, No. 4Can the preterm lung recover from perinatal stress?13 April 2016 | Molecular and Cellular Pediatrics, Vol. 3, No. 1Hydrogen-rich water ameliorates bronchopulmonary dysplasia (BPD) in newborn rats4 February 2016 | Pediatric Pulmonology, Vol. 51, No. 9Maternal high-fat diet is associated with impaired fetal lung developmentReina S. Mayor, Katelyn E. Finch, Jordan Zehr, Eugenia Morselli, Michael D. Neinast, Aaron P. Frank, Lisa D. Hahner, Jason Wang, Dinesh Rakheja, Biff F. Palmer, Charles R. Rosenfeld, Rashmin C. Savani, and Deborah J. Clegg15 August 2015 | American Journal of Physiology-Lung Cellular and Molecular Physiology, Vol. 309, No. 4Change in practice after the Surfactant, Positive Pressure and Oxygenation Randomised Trial29 May 2014 | Archives of Disease in Childhood - Fetal and Neonatal Edition, Vol. 99, No. 5Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasiaAlicia Madurga, Ivana Mižíková, Jordi Ruiz-Camp, and Rory E. Morty15 December 2013 | American Journal of Physiology-Lung Cellular and Molecular Physiology, Vol. 305, No. 12 More from this issue > Volume 301Issue 6December 2011Pages L858-L859 Copyright & PermissionsCopyright © 2011 the American Physiological Societyhttps://doi.org/10.1152/ajplung.00314.2011PubMed21964401History Received 23 September 2011 Accepted 23 September 2011 Published online 1 December 2011 Published in print 1 December 2011 Metrics